The potential of remote patient monitoring has moved well past the pilot stage. What started as a pandemic-era workaround is now a durable part of how care gets delivered in the United States. For the RPM companies, chronic care management groups, and telehealth platforms building programs today, the question is where it goes next.
This article looks at the current state of remote patient monitoring, the evidence behind it, and the forces shaping its future. We cover market size, adoption, Medicare billing changes, and the technologies that will define the next several years of connected care.
Where Remote Patient Monitoring Stands Now
Remote patient monitoring uses connected devices to collect health data at home and transmit it to a care team. Blood pressure cuffs, glucometers, weight scales, and pulse oximeters send readings automatically, so clinicians can review trends between visits instead of waiting for the next appointment.
The market reflects how far this has come. The global remote patient monitoring market was valued at roughly $31.8 billion in 2025 and is projected to reach $66.2 billion by 2031, growing at a compound annual growth rate of about 12.8%, according to MarketsandMarkets. Other forecasts run higher, but the direction is consistent across every credible estimate: sustained double-digit growth for the rest of the decade.
Adoption is climbing alongside the market. A 2025 analysis of US hospitals found that a rapidly increasing share now offer remote monitoring services, though availability still varies widely by hospital size, type, and region. Hospitals serving disadvantaged communities, which often have the worst readmission outcomes, tend to have the lowest RPM availability. That gap is one of the clearest opportunities in the field.
Two forces are driving all of this. First, chronic disease keeps rising as the population ages. The number of Americans aged 65 and older is projected to grow from 58 million in 2022 to 82 million by 2050, according to the Population Reference Bureau. Second, the healthcare workforce cannot keep pace with demand. Remote patient monitoring lets a single care team watch a large panel of patients without a live visit for every data point.
The Evidence Behind the Potential
The case for remote patient monitoring rests on outcomes, not just growth charts. Across chronic disease programs, RPM has consistently reduced acute care use.
A survey of 25 organizations found that hospital admissions for chronic complications dropped between 19% and 41% after implementing remote monitoring. The University of Pittsburgh Medical Center reported that adding RPM for high-risk patients lowered its 30-day readmission rate by 76%. In heart failure specifically, remote monitoring and team-based care models have cut 30-day readmissions in half in several published programs.
A systematic review from BMJ Open found that remote patient monitoring effectively reduces acute hospital events for conditions such as cardiovascular disease and COPD. A follow-up realist review by the same team concluded that RPM programs are more likely to work when they are designed around the patient, the provider, and the setting. The review pointed to several shared traits of successful programs:
- Targeting populations at genuine high risk
- Detecting a decline in health accurately
- Providing responsive, timely care
- Personalizing the care plan
- Strengthening patient self-management
- Coordinating care across the team
These findings matter because they separate remote patient monitoring that works from technology that simply collects data. The potential is real, but it depends on program design, not the hardware alone. The benefits of RPM for chronic disease management show up most clearly in programs built around these principles.
The 2026 CMS Changes That Expand the Potential
Reimbursement shapes adoption, and 2026 brought the most significant billing update since RPM codes were introduced. The Centers for Medicare and Medicaid Services (CMS) finalized the Calendar Year 2026 Physician Fee Schedule in the fall of 2025, adding two new CPT codes effective January 1, 2026.
CPT 99445 covers device supply and data transmission for 2 to 15 days of readings in a 30-day period. Until now, providers needed 16 days of data to bill the device supply code 99454. Patients who transmitted for only 12 days went unbilled, even though the clinical work was real. Code 99445 is reimbursed at roughly the same rate as 99454, around $52 per month. Providers choose one or the other for a given patient in a given period, since the two cannot be billed together.
CPT 99470 covers the first 10 minutes of treatment management time, reimbursed at about $26 per month, provided the month includes at least one real-time interactive communication with the patient or caregiver. Before this, a clinician who spent 17 productive minutes with a patient could not bill anything, because the existing code 99457 required a full 20 minutes.
These two additions lower the entry threshold for remote patient monitoring in a practical way. They fit short-term situations well: post-discharge monitoring, a medication change, or a condition where 16 days of readings is hard to reach. For channel partners building programs, the new codes widen the range of patients a program can serve and bill for responsibly.
The rest of the RPM code family stays in place. Setup (99453), device supply for 16 or more days (99454), the first 20 minutes of management (99457), and each additional 20 minutes (99458) all remain, so the new codes expand the framework rather than replace it.
What Comes Next: The Future Potential of Remote Patient Monitoring
The near-term future of remote patient monitoring is defined by a shift from passive data collection to active, intelligent care. Several developments are driving that shift.
Artificial Intelligence and Predictive Analytics
The most important change is what happens to the data after it arrives. Historically, most physiologic data was never integrated into care. AI now filters the noise and surfaces the patterns that matter, which turns a stream of readings into an early warning system. Instead of a clinician scanning hundreds of daily readings, models flag the handful of patients whose trends suggest trouble ahead.
This moves remote patient monitoring from reactive to predictive. Applied well, predictive models trained on large volumes of monitoring data could alert care teams to a decline before symptoms appear. The FDA’s finalized guidance on predetermined change control plans now lets AI-enabled devices evolve after they reach the market, which removes a barrier that slowed earlier tools.
Next-Generation Wearables and Continuous Data
Wearables are moving from fitness tracking toward medical-grade monitoring. Newer devices track heart rate variability, oxygen saturation, sleep quality, and other markers continuously rather than at a single daily reading. Contactless approaches, such as radar-based and Wi-Fi sensing systems that measure vital signs without a worn device, are also emerging.
Continuous data changes what remote patient monitoring can catch. A once-daily blood pressure reading shows a snapshot. A continuous stream shows the trend, and the trend is where early intervention lives. Recent wearable remote patient monitoring research points to expanding use beyond cardiovascular care into metabolic and neurological conditions.
Hybrid Care as the Default Model
Remote patient monitoring is becoming one layer of a blended care model rather than a standalone service. In a hybrid model, a patient might complete intake online, have a short video check-in, and come into the office only when a hands-on exam is needed. Remote monitoring supplies the continuous data layer that holds the whole model together between visits. Some estimates put the share of US medical visits happening remotely at 25% to 30% by the end of 2026.
Beyond Hardware: Continuity of Care
As programs mature, the hardware matters less than the continuity of data it produces. A durable monitoring program, built on infrastructure like the Tenovi Cellular Gateway, keeps a patient’s measurement history intact even when a device is swapped or upgraded. That continuity is what lets a care team see a full picture over months and years, and it is where the long-term value of remote patient monitoring accrues for both patients and the organizations serving them.
Frequently Asked Questions About the Potential of Remote Patient Monitoring
1) What is the potential of remote patient monitoring in healthcare?
The potential of remote patient monitoring lies in shifting care from reactive to proactive. By collecting vital sign data at home and transmitting it to a care team, remote patient monitoring supports earlier intervention, fewer hospital readmissions, and continuous oversight of chronic conditions between visits. The global RPM market is projected to reach roughly $66 billion by 2031, reflecting broad confidence in that potential.
2) How much is the remote patient monitoring market expected to grow?
Forecasts vary by firm, but most credible estimates project sustained double-digit growth through 2030 and beyond. MarketsandMarkets values the global market at about $31.8 billion in 2025, growing to $66.2 billion by 2031 at a compound annual growth rate near 12.8%. Aging populations and rising chronic disease are the primary drivers.
3) What are the new 2026 CMS remote patient monitoring codes?
CMS added two CPT codes effective January 1, 2026. Code 99445 covers device supply for 2 to 15 days of data in a 30-day period, reimbursed at roughly the same rate as 99454. Code 99470 covers the first 10 minutes of treatment management time, provided the month includes at least one real-time interactive communication with the patient or caregiver. Both lower the threshold to bill for shorter-duration monitoring.
4) Does remote patient monitoring actually reduce hospital readmissions?
Evidence across multiple programs shows it can. One survey of 25 organizations found chronic complication admissions dropped 19% to 41% after implementing RPM, and UPMC reported a 76% reduction in 30-day readmissions for high-risk patients. Results depend heavily on program design, including risk targeting, timely response, and coordinated care.
5) How will AI change remote patient monitoring?
AI is moving remote patient monitoring from passive data collection to predictive care. Instead of clinicians reviewing every reading, models identify the patients whose trends signal a coming decline and surface actionable insights. Combined with next-generation wearables and continuous data, AI supports earlier intervention and helps care teams manage larger patient panels efficiently.
Understanding the Potential of Remote Patient Monitoring
The potential of remote patient monitoring in 2026 is grounded in evidence, supported by expanded Medicare reimbursement, and pointed toward a future of AI-assisted, predictive, continuous care. The market is growing at double digits, outcomes data shows clear reductions in readmissions and emergency visits, and the 2026 CPT codes lower the barrier to launching a program. The next phase belongs to organizations that pair strong technology with strong program design and treat remote monitoring as proactive, preventive care rather than a billing line.
Tenovi provides the connected-device infrastructure behind hundreds of remote patient monitoring programs. Our plug-and-play Cellular Gateway pairs with more than 40 FDA-cleared devices and transmits readings automatically, with no apps and no syncing for patients. To see how Tenovi can power your program, contact us for a free demo and consultation.
